Azithromycin, the multidrug-resistant protein, and cystic fibrosis [4]

Lancet

Volumn 351, Issue 9111, 1998, Pages 1286-

  Altschuler, E L ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZITHROMYCIN; GLYCOPROTEIN P; MULTIDRUG RESISTANCE PROTEIN; TRANSMEMBRANE CONDUCTANCE REGULATOR;

CLINICAL TRIAL; CYSTIC FIBROSIS; DRUG USE; HUMAN; LETTER; LUNG FUNCTION; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 0032565369     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(05)79350-8     Document Type: Letter

References (3)

1. A Jaffé J Francis M Rosenthal A Bush Long-term azithromycin may improve lung function in children with cystic fibrosis Lancet 351 1998 420
2. JY Lallemand V Stoven Annereau JP Induction by antitumoral drugs of proteins that functionally complement CFTR: a novel therapy for cystic fibrosis? Lancet 350 1997 711 712
3. TW Grant CK O'Connor R Corbitt U Thorgeirsson SS Thorgeirsson In vitro induction of live p-glycoprotein expression by xenobiotics in monkeys Toxicol Appl Pharmacol 133 1995 269 276